Stocks & Investing
Wed, September 4, 2024
Thu, August 8, 2024
[ 12:00 AM ] - WOPRAI
Fri, July 19, 2024
[ 12:00 AM ] - WOPRAI
Mon, July 1, 2024
Fri, June 21, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 31, 2024
Fri, May 19, 2023
[ 12:00 AM ] - WOPRAI
Mon, January 11, 2021
[ 12:00 AM ] - WOPRAI
Fri, October 30, 2020
[ 12:00 AM ] - WOPRAI
Mon, October 19, 2020
[ 12:00 AM ] - WOPRAI
Tue, April 28, 2020
[ 12:00 AM ] - WOPRAI
Mon, December 11, 2017
Thu, November 9, 2017
[ 12:00 AM ] - WOPRAI
Wed, October 11, 2017
Tue, July 11, 2017
[ 12:00 AM ] - WOPRAI
Wed, October 5, 2016
[ 12:00 AM ] - WOPRAI
Thu, September 29, 2016
[ 12:00 AM ] - WOPRAI
Mon, February 1, 2016
[ 12:00 AM ] - WOPRAI
Mon, December 7, 2015
[ 12:00 AM ] - WOPRAI
Fri, October 23, 2015
[ 12:00 AM ] - WOPRAI
Wed, September 9, 2015 Biren Amin Initiated (BBIO) at Buy and Held Target at $46 on, Sep 4th, 2024
Biren Amin of Piper Sandler, Initiated "BridgeBio Pharma, Inc." (BBIO) at Buy and Held Target at $46 on, Sep 4th, 2024.
Biren has made no other calls on BBIO in the last 4 months.
There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Biren's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Biren
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Tuesday, September 3rd, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $43 on, Wednesday, August 7th, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Decreased Target to $45 on, Wednesday, August 7th, 2024
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, July 1st, 2024
- Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, June 25th, 2024
- Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024
